期刊文献+

益肾饮联合雷公藤多甙纠正系膜增生性肾炎中脂质代谢紊乱的实验研究 被引量:2

Experimental study on Yishenyin combined with Glucosida Tripterygii TOTA in rectifying dyslipidosis induced by mesangial proliferative glomerulonephritis in rats
暂未订购
导出
摘要 目的探讨益肾饮联合雷公藤多甙对大鼠系膜增生性肾小球肾炎中脂质代谢的影响。方法实验大鼠随机分为空白对照A组、模型B组、雷公藤多甙C组、益肾饮D组、雷公藤多甙和益肾饮合用E组。B、C、D、E组制备大鼠系膜增生性肾小球肾炎模型,并以相应药物灌胃;采用ELISA法测定各组血清总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白胆固醇(LDL-C)水平。结果模型制备成功后,大鼠肾脏系膜细胞增生明显,血清TC、TG、LDL-C水平均不同程度升高;C、D、E组肾脏系膜细胞增生均减轻,血清TC、TG、LDL-C水平均较B组下降,且E组更为明显。结论益肾饮联合雷公藤多甙能有效地纠正系膜增生性肾小球肾炎引起的脂质代谢紊乱,减轻系膜细胞的增生。 Objective It is to approach the influence of Yishenyi and Glucosida Tripterygii TOTA on lipid metabolism in rats with mesangial proliferative glomerulonephritis. Methods Experimental rats (50 days's age) were randomly divided into five groups: normal group (group A), model group (group B), Glucosida Tripterygii TOTA group (group C), Yishenyin group (group D) and Yishenyin combined with Glucosida Tripterygii TOTA group (group E). Rat models of mesangial protiferative glomerulonephritis were established and were treated with corresponding drugs by intragastric administration in group B, C, D and E. The levels of total cholesterol (TC), triglycerides and low density lipoprotein cholesterol (LDL- C) in serum were detected by ELISA. Results After the rat models of mesangial proliferative glomerulonephritis were established successfully, the levels of TC, TG and LDL- C in rats were obviously elevated. After treatment, the membrane proliferation and the levels of serum TC, TG and LDL C in group C, D and E were all reduced, and the effect was markedly in group E. Conclusion Yishenyin combined with Glucosida Tripterygii TOTA could effectively rectify dyslipidosis and reduce the membrane proliferation induced by mesangial proliferative glomerulonephritis.
出处 《现代中西医结合杂志》 CAS 2009年第9期984-986,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 益肾饮 雷公藤多甙 系膜增生性肾小球肾炎 胆固醇 三酰甘油 低密度脂蛋白胆固醇 Yishenyin Glucosida Tripterygii TOTA mesangial proliferative glomerulonephritis cholesterol triglycerides low density lipoprotein cholesterol
  • 相关文献

参考文献5

二级参考文献13

  • 1贾慧,邹万忠.改良慢性血清病性大鼠系膜增生性肾炎模型的建立[J].肾脏病与透析肾移植杂志,1996,5(3):21-25. 被引量:57
  • 2吴桂艳,于俊生.肾小球肾炎中炎症细胞因子的表达及中药对其产生的影响[J].中国中西医结合肾病杂志,2007,8(4):246-248. 被引量:15
  • 3丁樱 任献青.肾必宁冲剂对系膜增殖性肾炎大鼠TNF-α和系膜的影响[J].中医儿科,2000,1(1):13-15.
  • 4肖黎 丁樱 张红敏.肾必宁冲剂对肾小球系膜细胞凋亡bcl-2,ICE表达的影响[J].中医儿科,2000,1(3):111-112.
  • 5丁樱 未林.肾必宁对慢性血清病性系膜增生性肾小球肾炎肾小球系膜区细胞凋亡的影响研究[J].中医儿科,2001,2(3):108-108.
  • 6卫艳玲 于俊生.雷公藤多甙治疗肾脏疾病所致毒副作用中医病机的探讨.中华医学百科杂志,2006,82:36-36.
  • 7Timoshanko JR, Sedgwick JD, Holdsworth SR, et al. Intrinsic renal cells are the major source of tumor necrosis factor contributing to renal injury in murine crescentic glomerulonephritis. Am Soe Nephrol,2003,14(7):1785- 1793.
  • 8Carnussi G,Turello E, Tetta C, et al. Tumor necrosis factor induces contraction of mesangial cells and alters their cytoskeletons. Kindey Int, 1990,38(5) :795 - 802.
  • 9邹万忠等.肾脏病理与临床[M]湖南科学技术出版社,1993.
  • 10陈香美,王建中,傅博,于力方.精-甘-天-丝四肽对肾小球系膜细胞凋亡相关基因的作用[J].中华医学杂志,1998,78(1):59-62. 被引量:2

共引文献82

同被引文献18

  • 1方玲,钟建庭.强直性脊柱炎的诊治现状[J].中国医师进修杂志,2006,29(7):69-71. 被引量:10
  • 2Spoorenberg A,Van Der Heijde D,De Klerk E,et al.A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis[J].J Rheumatol,1999,26(4):961-965.
  • 3Heikkil S,Viitanen JV,Kautianen H,et al.Evaluation of the finnish versions of the functional indices BASFI and DFI in spondylarthropathy[J].Clin Rheumatol,2000,19(6):464-469.
  • 4Garrett S,Jenkinson T,Kennedy LG,et al.A new approach to defining disease status in ankylosing spondylitis:the Bath Ankylosing Spondylitis Disease Activity Index[J].J Rheumatol,1994,21(12):2286-2291.
  • 5Nas K,Yildirim K,Cevik R,et al.Discrimination ability of ASDAS estimating disease activity status in patients with ankylosing spondylitis[J].Int J Rheum Dis,2010,13(3):240-245.
  • 6Eder L,Chandran V,Shen H,et al.Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis[J].Ann Rheum Dis,2010,69(12):2160-2164.
  • 7Aydin SZ,Can M,Atagunduz P,et al.Active disease requiring TNF-alpha-antagonist therapy can be well discriminated with different ASDAS sets:a prospective,follow-up of disease activity assessment in ankylosing spondylitis[J].Clin Exp Rheumatol,2010,28(5):752-755.
  • 8Pedersen SJ,Sorensen IJ,Hermann KG,et al.Responsiveness of the ankylosing spondylitis disease activity score(ASDAS)and clinical and MRI measures of disease activity in a1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors[J].Ann Rheum Dis,2010,69(6):1065-1071.
  • 9Pedersen SJ,Sorensen IJ,Garnero P,et al.ASDAS,BASDAI and different treatment responses and their relation to biomarkers of inflammation,cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFαinhibitors[J].Ann Rheum Dis,2011,70(8):1375-1381.
  • 10丁育民.雷公藤多甙治疗强直性脊柱炎的临床观察[J].甘肃中医学院学报,1998,15(1):21-22. 被引量:8

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部